“PD-L1 expression remains the gold standard”
“PD-L1 expression remains the gold standard”
Jarushka Naidoo
ELCC 2022 - Jarushka Naidoo Jarushka Naidoo depic
Lizza Hendriks
ELCC 2022 - Lizza Hendriks Lizza Hendriks discuss
Jordi Remon
ELCC 2022 - Jordi Remon Jordi Remon outlines what
SCLC: prognostic determinants and new treatment modalities
SCLC: prognostic determinants and new treatment
Oncogene-driven lung cancer: EGFR, METex14, ROS1, RET
Oncogene-driven lung cancer: EGFR, METex14, ROS1
Looking more closely at upcoming and established immunotherapy standards
Looking more closely at upcoming and established
Preface
Preface Fred R. Hirsch, MD, PhD, FASCO Center
抗血管生成组合在后线中表现优异
抗血管生成组合在后线中表现优异 VARGADO：免疫疗法后的尼达尼布（nintedanib） 正在进行
“当需要快速缓解时，化疗必不可少”
“当需要快速缓解时，化疗必不可少” Anne-Marie C. Dingemans, MD, PhD,
